CIFoundry
Back to Catalog
Oncology
FDA Cleared

ScreenPoint Transpara

Save to shortlist
ScreenPoint Medical B.V.2020

Last reviewed Nov 11, 2026 against the sources listed on this page · How we review

At a glance

Transpara is an FDA-cleared breast AI system that supports radiologists reading 2D mammography and 3D tomosynthesis by detecting suspicious calcifications and soft-tissue lesions and providing a…

FDA:
510(k) K260898 +4 more
Epic:
Not on record
Named users:
5 named in public reports
Published study:
Yes, linked below

Description

Transpara is an FDA-cleared breast AI system that supports radiologists reading 2D mammography and 3D tomosynthesis by detecting suspicious calcifications and soft-tissue lesions and providing a Transpara Score that reflects the likelihood of malignancy. It is validated for concurrent reading, second reading and reader-workload triage, and is deployed in screening programs across Europe and the US.

mammographybreast cancertomosynthesisscreeningsecond readerFDA-clearedwomen's health

Quick answers

Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review

Is ScreenPoint Transpara FDA cleared?
The public FDA database has 5 records that our team matched to ScreenPoint Transpara. The most recent is 510(k) K260898 (Transpara (2.1.0)), decided Aug 2026. Check that the cleared use matches how you plan to use it.FDA record K260898
Which health systems use ScreenPoint Transpara?
Linked public reports name 5 organizations: Riverside Health System, Fairfax Radiology, Johns Hopkins Medicine and 2 more. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Riverside Health System (Riverside Health System) Fairfax Radiology (PR Newswire) Johns Hopkins Medicine (ScreenPoint Medical)
Is there published research on ScreenPoint Transpara?
Yes, this listing links a study (prospective / randomized study). Check whether the patients and setting in the study look like yours.Read the study

Security & contracting

The maker has not reported these details yet. Ask the vendor directly during evaluation.

Workflow stage
Not reported
Integrations
Not reported
Data inputs
Not reported
Deployment
Not reported
Signs a BAA
Not reported
SOC 2 report
Not reported
HITRUST
Not reported
Evidence type
Prospective / randomized study

Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.

Who's using this

5 organizations

Organizations named in public announcements or by the developer. Inclusion is not an endorsement.

Last checked Nov 9, 2026. Spot an error? Let us know through the discussion below.

Get weekly updates for Oncology

Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.

Sources

This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.

Website Research Paper

FDA database records

  • K260898 · 510(k) · Aug 2026
    Transpara (2.1.0)
  • K241831 · 510(k) · Nov 2024
    Transpara (2.1.0)
  • K232096 · 510(k) · Dec 2023
    Transpara Density 1.0.0
  • K221347 · 510(k) · Aug 2022
    Transpara 1.7.2
  • K210404 · 510(k) · Jun 2021
    Transpara 1.7.0

Matched by our team from the public FDA database; checked Nov 10, 2026.

History (11)Show

Dated events on this listing's public record, newest first.

  1. Sep 13, 2026

    Added to CIFoundry

  2. Aug 14, 2026

    FDA 510(k) K260898 decision datesource

  3. Mar 19, 2026

    News report names Middlesex Hospital as a user (CHEFA)source

  4. Nov 25, 2024

    FDA 510(k) K241831 decision datesource

  5. Mar 12, 2024

    News report names Johns Hopkins Medicine as a user (ScreenPoint Medical)source

  6. Dec 11, 2023

    FDA 510(k) K232096 decision datesource

  7. Sep 25, 2023

    News report names Riverside Health System as a user (Riverside Health System)source

  8. May 4, 2023

    News report names Fairfax Radiology as a user (PR Newswire)source

  9. Aug 3, 2022

    FDA 510(k) K221347 decision datesource

  10. Nov 9, 2021

    News report names Capital Region of Denmark (Copenhagen) as a user (PR Newswire)source

  11. Jun 2, 2021

    FDA 510(k) K210404 decision datesource

https://www.screenpoint-medical.com/contact (HQ: Nijmegen, Netherlands)

Developer

ScreenPoint Medical

ScreenPoint Medical B.V.

Evaluating this tool?

Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.

Prepare evaluation packet

Checklist for your role: Admin · Physician · IT · Compliance

Compare similar tools →

Own this tool?

Claim this listing to update its details and connect with your audience.